JP2006501166A5 - - Google Patents

Download PDF

Info

Publication number
JP2006501166A5
JP2006501166A5 JP2004510825A JP2004510825A JP2006501166A5 JP 2006501166 A5 JP2006501166 A5 JP 2006501166A5 JP 2004510825 A JP2004510825 A JP 2004510825A JP 2004510825 A JP2004510825 A JP 2004510825A JP 2006501166 A5 JP2006501166 A5 JP 2006501166A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
heterologous
immunogenic
immunogenic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004510825A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006501166A (ja
Filing date
Publication date
Priority claimed from GB0213364A external-priority patent/GB0213364D0/en
Priority claimed from GB0221689A external-priority patent/GB0221689D0/en
Application filed filed Critical
Priority claimed from PCT/EP2003/006095 external-priority patent/WO2003103706A2/en
Publication of JP2006501166A publication Critical patent/JP2006501166A/ja
Publication of JP2006501166A5 publication Critical patent/JP2006501166A5/ja
Pending legal-status Critical Current

Links

JP2004510825A 2002-06-11 2003-06-06 異種前立腺タンパク質ｐ５０１ｓを含む免疫原性組成物 Pending JP2006501166A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0213364A GB0213364D0 (en) 2002-06-11 2002-06-11 Vaccine
GB0221689A GB0221689D0 (en) 2002-09-18 2002-09-18 Vaccine
PCT/EP2003/006095 WO2003103706A2 (en) 2002-06-11 2003-06-06 Immunogenic compositions

Publications (2)

Publication Number Publication Date
JP2006501166A JP2006501166A (ja) 2006-01-12
JP2006501166A5 true JP2006501166A5 (https=) 2006-06-22

Family

ID=29738081

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004510825A Pending JP2006501166A (ja) 2002-06-11 2003-06-06 異種前立腺タンパク質ｐ５０１ｓを含む免疫原性組成物

Country Status (6)

Country Link
US (1) US20060140965A1 (https=)
EP (1) EP1511513A2 (https=)
JP (1) JP2006501166A (https=)
AU (1) AU2003250828A1 (https=)
CA (1) CA2487907A1 (https=)
WO (1) WO2003103706A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050276758A1 (en) * 2004-06-15 2005-12-15 Marshall Deborah J Method for screening agents against human prostate disease
CN101257920B (zh) * 2005-06-21 2012-09-05 塞莱克蒂斯股份有限公司 与抗前列腺癌疫苗有关的方法和组合物
WO2010022225A1 (en) * 2008-08-20 2010-02-25 Ibc Pharmaceuticals, Inc. Dock-and-lock (dnl) vaccines for cancer therapy
EP3592800A4 (en) 2017-03-10 2021-01-06 Bolt Threads, Inc. COMPOSITIONS AND METHODS OF PRODUCING HIGHLY SECRETED YIELD OF RECOMBINANT PROTEIN
KR20250121449A (ko) 2017-03-10 2025-08-12 볼트 쓰레즈, 인크. 재조합 단백질을 고분비 수율로 생산하기 위한 조성물 및 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046769A1 (en) * 1997-04-11 1998-10-22 Dendreon Corporation Composition and method for inducing an immune response against tumour-related antigens
CA2322624A1 (en) * 1998-03-20 1999-09-23 Genzyme Corporation Induction of immunity against tumor self-antigens
CN100419079C (zh) * 1998-07-14 2008-09-17 科里克萨有限公司 用于治疗和诊断前列腺癌的组合物和方法
AU7859900A (en) * 1999-10-04 2001-05-10 Corixa Corporation Compositions and methods for wt1 specific immunotherapy
US20020009455A1 (en) * 2000-04-27 2002-01-24 Ted Lau DNA encoding a novel PROST 03 polypeptide

Similar Documents

Publication Publication Date Title
EP1053325B1 (en) Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
WO2017191264A1 (en) Nucleic acid molecules and uses thereof
US20190343942A1 (en) Rna encoding a tumor antigen
ES2365077T3 (es) Péptido antígeno anticáncer derivado de sparc y composición farmacéutica que comprende el mismo.
RU2013152648A (ru) Аденовирус обезьян и гибридные аденовирусные векторы
JP2013537422A (ja) ヒトパピローマウイルス変形体及び免疫増強剤を含む子宮頸癌の予防または治療用組成物
JP2008056679A5 (https=)
JP2004121263A (ja) 子宮頸がんの治療
JP2013526837A5 (https=)
ES2398492T3 (es) Proteínas de fusión que comprenden los antígenos de rechazo tumoral NY-ESO-1 y LAGE-1
JP2020510426A5 (https=)
CN1921882A (zh) 同种异基因肿瘤治疗剂
EP4110385A1 (en) Compositions comprising ltb and pathogenic antigens, and use thereof
RU2006132340A (ru) Слитые белки карциноэмбрионального антигена
TWI415623B (zh) 使用小泛素相關融合蛋白表現系統製備類病毒粒子的方法
KR102148413B1 (ko) 이종 폴리펩티드를 포함하는 ＣｙａＡ에 기초한 키메라 단백질 및 면역 반응의 유도에 있어서의 그의 용도
CN101096680A (zh) 一种dna疫苗真核表达载体及其在制备基因疫苗中的应用
JP2006501166A5 (https=)
CN120324597A (zh) 编码肿瘤抗原表位的mRNA疫苗及其制备方法和用途
CN111118063B (zh) 以FAPα和survivin为基础的DNA及其在制备肿瘤疫苗中的应用
CN113072646A (zh) 靶向egfr的肿瘤核酸疫苗
JP2007511534A5 (https=)
CN110139875B (zh) Col14a1衍生的肿瘤抗原多肽及其应用
CN105801704B (zh) 一种具有抗宫颈癌细胞活性的重组疫苗构建方法及应用
CN101361983B (zh) 一种肺癌dna质粒疫苗及其制备方法